{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:59:26Z","timestamp":1794808766240,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the efficacy and safety of first\u2010line antiretroviral treatment (ART) with 2DR dolutegravir\/lamivudine (DTG\/3TC) versus 3DR bictegravir\/tenofovir alafenamide\/emtricitabine (BIC\/TAF\/FTC) in persons with low CD4 cell counts and\/or an AIDS\u2010defining disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective, multicentre, multinational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, multicentre, multinational analysis to investigate the virological response and discontinuation rate in people living with HIV starting first\u2010line ART with a CD4 cell count &lt;200\/\u03bcL and\/or an AIDS\u2010defining condition. Proportions of discontinuations were compared using univariate analysis. Virological response was analyzed using FDA snapshot analysis (HIV\u20101 RNA &lt;50 copies\/mL at week 48).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two hundred and fifty\u2010nine people who were diagnosed late with HIV were included in the study. Sixty\u2010nine of them were started on 2DR DTG\/3TC and 190 on 3DR BIC\/TAF\/FTC. After matching 1 to 1 (matching criteria: age, sex, CD4 cell count, HI\u2010viral load, Centers for Disease Control and Prevention (CDC) stage,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200962 per group), the mean baseline CD4 cell count was 121\/\u03bcL (standard deviation [SD] 65), including 21% presenting with an AIDS\u2010defining condition. 96.2% and 91.8% of people living with HIV on 2DR and 3DR, respectively, had a viral load &lt;50 copies\/mL at week 48 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.244). No significant differences in discontinuation rates were observed at week 48 (5.5% in the 2DR and 9.4% in the 3DR group;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.301).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a European cohort of people diagnosed late with HIV who started first\u2010line ART either with 2DR DTG\/3TC or 3DR BIC\/TAF\/FTC, there were no significant differences in virological response and discontinuation rates after 48\u2009weeks of treatment. With respect to the relatively small sample size and the inherent constraints of the study design, the possibility of establishing causal inference remains limited, and prospective studies are needed to further investigate on this topic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hiv.70119","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T07:54:53Z","timestamp":1759823693000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG\/3TC or BIC\/TAF\/FTC: A real\u2010world cohort analysis"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-4116","authenticated-orcid":false,"given":"Gundolf","family":"Schuettfort","sequence":"first","affiliation":[{"name":"University Hospital Frankfurt  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Borch","sequence":"additional","affiliation":[{"name":"Praxis Goldstein  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-8358","authenticated-orcid":false,"given":"Alfonso","family":"Cabello","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundacion Jimenez Diaz Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, (IIS\u2010FJD, UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Crusells","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario Lozano Blesa  Zaragoza Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundacion Jimenez Diaz Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, (IIS\u2010FJD, UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[{"name":"University Hospital Frankfurt  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-5728","authenticated-orcid":false,"given":"Carmen","family":"Hidalgo\u2010Tenorio","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de las Nieves  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lopez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Gregorio Maranon  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6626-4266","authenticated-orcid":false,"given":"Rafael","family":"Mican","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Navarro\u2010Soler","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Negredo","sequence":"additional","affiliation":[{"name":"Universitario Germans Trias i Pujol Fundaci\u00f3 Lluita contra les Infeccions, Universitat de Vic\u2010Universitat Central de Catalunya, CIBERINFEC  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Noe","sequence":"additional","affiliation":[{"name":"MVZ Muenchen am Goetheplatz  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Puig","sequence":"additional","affiliation":[{"name":"Universitario Germans Trias i Pujol Fundaci\u00f3 Lluita contra les Infeccions, Universitat de Vic\u2010Universitat Central de Catalunya, CIBERINFEC  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pulido","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Serrao","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-3888","authenticated-orcid":false,"given":"Juergen","family":"Rockstroh","sequence":"additional","affiliation":[{"name":"University Hospital Bonn  Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Getafe  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-9006","authenticated-orcid":false,"given":"Christoph","family":"Stephan","sequence":"additional","affiliation":[{"name":"University Hospital Frankfurt  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Torralba","sequence":"additional","affiliation":[{"name":"Hospital Universitario Guadalajara DISCAM  Guadalajara Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva","family":"Trigo","sequence":"additional","affiliation":[{"name":"Hospital Professor Doutor Fernando Fonseca  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vehreschild","sequence":"additional","affiliation":[{"name":"University Hospital Frankfurt  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette E.","family":"Haberl","sequence":"additional","affiliation":[{"name":"University Hospital Frankfurt  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20101293.2010.00857.x"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.01.017"},{"key":"e_1_2_12_4_1","unstructured":"www.ecdc.europa.eu. Accessed January 6 2025."},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12708"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12962"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2021.10.004"},{"key":"e_1_2_12_8_1","unstructured":"www.iasusa.org\/2014\/12\/01\/antiretroviral\u2010drugs\u2010treatment\u2010prevention\u2010hiv\u2010adults\u20102024\u2010recommendations\u2010of\u2010the\u2010international\u2010\u2010antiviral\u2010society\u2010usa\u2010panel\/. Accessed January 8 2025."},{"key":"e_1_2_12_9_1","unstructured":"www.eacsociety.org\/guidelines\/eacs-guidelines\/. Accessed January 8 2025."},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002275"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cia036"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac130"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002979"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)32299\u20107"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101991"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107016"},{"key":"e_1_2_12_17_1","unstructured":"BehrensG AssoumouL LiegeonG et al.Integrase Inhibitor Versus Protease Inhibitor Based Therapy for People with Advanced HIV Disease (LAPTOP). CROI Conference 2025 Poster Number 0658."},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010\u2010023\u201002064\u20101"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020433"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12389"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/338929"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226724"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1423734"},{"key":"e_1_2_12_24_1","unstructured":"DOLCE study.https:\/\/clinicaltrials.gov\/study\/NCT04880395Accessed March 2025."},{"key":"e_1_2_12_25_1","unstructured":"FigueroaM.Comparable efficacy and safety of dolutegravir\/lamivudine to a three drug regimen amongst ARV na\u00efve people living with HIV with CD4 <200\/mm3: the DOLCE study. Presented at HIV Glasgow 2024 November 10\u201013 Glasgow Scotland;Oral O24."},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14030524"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107164"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265\u2010019\u201001247\u20101"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S437043"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12403"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S42328"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(10)70026\u20108"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328010f201"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.70119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T10:55:58Z","timestamp":1767351358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.70119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/hiv.70119"],"URL":"https:\/\/doi.org\/10.1111\/hiv.70119","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"2025-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}